Institutional Ownership
Alterity Therapeutics Ltd
CUSIP 02155X205SPONSORED ADSATHEQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
15
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Twin Lakes Capital Management, LLC | 139.3K | $484.6K |
| 2 | Hb Wealth Management, LLC | 58.5K | $203.4K |
| 3 | Morgan Stanley | 58.4K | $203.2K |
| 4 | Greenleaf Trust | 32.0K | $111.4K |
| 5 | Citadel Advisors LLC | 20.1K | $71.5K |
| 6 | Bnp Paribas Financial Markets | 6.8K | $23.7K |
| 7 | Rhumbline Advisers | 2.0K | $7.0K |
| 8 | Gamma Investing LLC | 1.9K | $6.5K |
| 9 | Osaic Holdings, Inc. | 68 | $240 |
| 10 | Blue Trust, Inc. | 40 | $139 |